The Health Department is offering the Sickle Cell Disease Treatment Demonstration Program Regional Collaborative grant to increase the number of providers treating sickle cell patients, prescribing disease-modifying therapies like hydroxyurea, and improving care for sickle cell patients. This grant aims to establish Sickle Cell Regional Collaboratives that enhance service delivery, genetic counseling, training of health professionals, and coordination of education and care for individuals with sickle cell disease.
Opportunity ID: 254268
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | HRSA-14-078 |
| Funding Opportunity Title: | Sickle Cell Disease Treatment Demonstration Program Regional Collaborative |
| Opportunity Category: | Discretionary |
| Opportunity Category Explanation: | – |
| Funding Instrument Type: | Cooperative Agreement |
| Category of Funding Activity: | Health |
| Category Explanation: | https://grants.hrsa.gov/webExternal/SFO.asp?ID=cd14b333-d38a-4ca0-af60-26f889217e19 |
| Expected Number of Awards: | 4 |
| Assistance Listings: | 93.365 — Sickle Cell Treatment Demonstration Program |
| Cost Sharing or Matching Requirement: | No |
| Version: | Synopsis 2 |
| Posted Date: | Apr 24, 2014 |
| Last Updated Date: | Apr 25, 2014 |
| Original Closing Date for Applications: | May 27, 2014 |
| Current Closing Date for Applications: | May 27, 2014 |
| Archive Date: | Jul 26, 2014 |
| Estimated Total Program Funding: | $3,400,000 |
| Award Ceiling: | $850,000 |
| Award Floor: | $0 |
Eligibility
| Eligible Applicants: | Others (see text field entitled “Additional Information on Eligibility” for clarification) |
| Additional Information on Eligibility: | Eligible entities for this cooperative agreement program are any Federally-qualified health center, nonprofit hospital or clinic, or university health center that provides primary health care that: (1) has a collaborative agreement with a community-based sickle cell disease organization or a nonprofit entity with experience in working with individuals with sickle cell disease; and (2) demonstrates that it, the collaborative entity, or the experts described in section 712(c)(2)(C) of the American Jobs Creation Act of 2004, has at least five (5) years¿ experience working with individuals who have sickle cell disease. Faith-based and community-based organizations that meet these qualifications are eligible. |
Additional Information
| Agency Name: | Health Resources and Services Administration |
| Description: | This announcement solicits applications for the Sickle Cell Treatment Demonstration Program Regional Collaborative. The purpose of this funding opportunity is to: (1) increase the number of providers that are treating sickle cell patients in the region; (2) increase the number of providers prescribing disease-modifying therapies, such as hydroxyrea; and (3) increase the number of sickle cell patients that are receiving care from providers with greater knowledge of how to treat sickle cell disease. This program will use collective impact strategies (see Collective Impact below) and collaborative learning to create Sickle Cell Regional Collaboratives that develop regional and sstate infrastructure to increase the number of providers providing disease-modifying therapies and enhancing the prevention and treatment of sickle cell disease through coordination of service delivery, genetic counseling and testing, bundling of technical services, training of health professionals, and efforts related to the expansion and coordination of education, treatment, and continuity of care for individuals with sickle cell disease. |
| Link to Additional Information: | – |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
Department of Health and Human Services, Health Resources and Services Administration, HRSA Grants Application Center, 910 Clopper Road, Suite 155 South, Gaithersburg, MD, 20878
CallCenter@HRSA.GOV Email:CallCenter@HRSA.GOV |
Version History
| Version | Modification Description | Updated Date |
|---|---|---|
| N/A | Apr 25, 2014 | |
| Apr 25, 2014 |
DISPLAYING: Synopsis 2
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | HRSA-14-078 |
| Funding Opportunity Title: | Sickle Cell Disease Treatment Demonstration Program Regional Collaborative |
| Opportunity Category: | Discretionary |
| Opportunity Category Explanation: | – |
| Funding Instrument Type: | Cooperative Agreement |
| Category of Funding Activity: | Health |
| Category Explanation: | https://grants.hrsa.gov/webExternal/SFO.asp?ID=cd14b333-d38a-4ca0-af60-26f889217e19 |
| Expected Number of Awards: | 4 |
| Assistance Listings: | 93.365 — Sickle Cell Treatment Demonstration Program |
| Cost Sharing or Matching Requirement: | No |
| Version: | Synopsis 2 |
| Posted Date: | Apr 24, 2014 |
| Last Updated Date: | Apr 25, 2014 |
| Original Closing Date for Applications: | May 27, 2014 |
| Current Closing Date for Applications: | May 27, 2014 |
| Archive Date: | Jul 26, 2014 |
| Estimated Total Program Funding: | $3,400,000 |
| Award Ceiling: | $850,000 |
| Award Floor: | $0 |
Eligibility
| Eligible Applicants: | Others (see text field entitled “Additional Information on Eligibility” for clarification) |
| Additional Information on Eligibility: | Eligible entities for this cooperative agreement program are any Federally-qualified health center, nonprofit hospital or clinic, or university health center that provides primary health care that: (1) has a collaborative agreement with a community-based sickle cell disease organization or a nonprofit entity with experience in working with individuals with sickle cell disease; and (2) demonstrates that it, the collaborative entity, or the experts described in section 712(c)(2)(C) of the American Jobs Creation Act of 2004, has at least five (5) years¿ experience working with individuals who have sickle cell disease. Faith-based and community-based organizations that meet these qualifications are eligible. |
Additional Information
| Agency Name: | Health Resources and Services Administration |
| Description: | This announcement solicits applications for the Sickle Cell Treatment Demonstration Program Regional Collaborative. The purpose of this funding opportunity is to: (1) increase the number of providers that are treating sickle cell patients in the region; (2) increase the number of providers prescribing disease-modifying therapies, such as hydroxyrea; and (3) increase the number of sickle cell patients that are receiving care from providers with greater knowledge of how to treat sickle cell disease. This program will use collective impact strategies (see Collective Impact below) and collaborative learning to create Sickle Cell Regional Collaboratives that develop regional and sstate infrastructure to increase the number of providers providing disease-modifying therapies and enhancing the prevention and treatment of sickle cell disease through coordination of service delivery, genetic counseling and testing, bundling of technical services, training of health professionals, and efforts related to the expansion and coordination of education, treatment, and continuity of care for individuals with sickle cell disease. |
| Link to Additional Information: | – |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
Department of Health and Human Services, Health Resources and Services Administration, HRSA Grants Application Center, 910 Clopper Road, Suite 155 South, Gaithersburg, MD, 20878
CallCenter@HRSA.GOV Email:CallCenter@HRSA.GOV |
DISPLAYING: Synopsis 1
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | HRSA-14-078 |
| Funding Opportunity Title: | Sickle Cell Disease Treatment Demonstration Program Regional Collaborative |
| Opportunity Category: | Discretionary |
| Opportunity Category Explanation: | – |
| Funding Instrument Type: | Cooperative Agreement |
| Category of Funding Activity: | Health |
| Category Explanation: | https://grants.hrsa.gov/webExternal/SFO.asp?ID=cd14b333-d38a-4ca0-af60-26f889217e19 |
| Expected Number of Awards: | 4 |
| Assistance Listings: | 93.365 — Sickle Cell Treatment Demonstration Program |
| Cost Sharing or Matching Requirement: | No |
| Version: | Synopsis 1 |
| Posted Date: | Apr 25, 2014 |
| Last Updated Date: | – |
| Original Closing Date for Applications: | – |
| Current Closing Date for Applications: | May 27, 2014 |
| Archive Date: | Jul 26, 2014 |
| Estimated Total Program Funding: | $3,400,000 |
| Award Ceiling: | $850,000 |
| Award Floor: | $0 |
Eligibility
| Eligible Applicants: | Others (see text field entitled “Additional Information on Eligibility” for clarification) |
| Additional Information on Eligibility: | Eligible entities for this cooperative agreement program are any Federally-qualified health center, nonprofit hospital or clinic, or university health center that provides primary health care that: (1) has a collaborative agreement with a community-based sickle cell disease organization or a nonprofit entity with experience in working with individuals with sickle cell disease; and (2) demonstrates that it, the collaborative entity, or the experts described in section 712(c)(2)(C) of the American Jobs Creation Act of 2004, has at least five (5) years¿ experience working with individuals who have sickle cell disease. Faith-based and community-based organizations that meet these qualifications are eligible. |
Additional Information
| Agency Name: | Health Resources and Services Administration |
| Description: | This announcement solicits applications for the Sickle Cell Treatment Demonstration Program Regional Collaborative. The purpose of this funding opportunity is to: (1) increase the number of providers that are treating sickle cell patients in the region; (2) increase the number of providers prescribing disease-modifying therapies, such as hydroxyrea; and (3) increase the number of sickle cell patients that are receiving care from providers with greater knowledge of how to treat sickle cell disease. This program will use collective impact strategies (see Collective Impact below) and collaborative learning to create Sickle Cell Regional Collaboratives that develop regional and sstate infrastructure to increase the number of providers providing disease-modifying therapies and enhancing the prevention and treatment of sickle cell disease through coordination of service delivery, genetic counseling and testing, bundling of technical services, training of health professionals, and efforts related to the expansion and coordination of education, treatment, and continuity of care for individuals with sickle cell disease. |
| Link to Additional Information: | – |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
Department of Health and Human Services, Health Resources and Services Administration, HRSA Grants Application Center, 910 Clopper Road, Suite 155 South, Gaithersburg, MD, 20878
CallCenter@HRSA.GOV Email:CallCenter@HRSA.GOV |
Related Documents
There are no related documents on this grant.
Packages
| Agency Contact Information: | Department of Health and Human Services, Health Resources and Services Administration, HRSA Grants Application Center, 910 Clopper Road, Suite 155 South, Gaithersburg, MD, 20878 CallCenter@HRSA.GOV Email: CallCenter@HRSA.GOV |
| Who Can Apply: | Organization Applicants |
| Assistance Listing Number | Competition ID | Competition Title | Opportunity Package ID | Opening Date | Closing Date | Actions |
|---|---|---|---|---|---|---|
| 93.365 | HRSA-14-078 | Sickle Cell Disease Treatment Demonstration Program Regional Collaborative | PKG00195739 | May 30, 2014 | View |
Package 1
Mandatory forms
254268 SF424_2_1-2.1.pdf
254268 PerformanceSite_1_4-1.4.pdf
254268 Project-1.1.pdf
254268 GG_LobbyingForm-1.1.pdf
254268 Budget-1.1.pdf
254268 SF424B-1.1.pdf
254268 SF424A-1.0.pdf
Share This Post, Choose Your Platform!
About the Author: osnqt
